Inside a first-of-its-kind coronavirus vaccine trial

Researchers at NYU have started clinical trials on a never-before-tried genetic vaccine. It carries “messenger RNA,” which instructs the cells to make the proteins associated with COVID-19 to possibly create antibodies that fight it off.